Ozempic: Weight Loss Drugs Led to Decline in U.S. Obesity Rate

Decline in U.S. Obesity Rate Linked to Weight Loss Drugs

A recent Gallup poll reveals a decline in the obesity rate among U.S. adults over the past three years, coinciding with a sharp increase in the use of GLP-1 weight loss drugs like Ozempic and Wegovy.

The poll indicates that women have a higher obesity rate than men and are more likely to use weight management medications. Additionally, individuals between the ages of 40 and 64 have higher obesity rates and utilize GLP-1 drugs more frequently.

However, despite the decline in obesity rates, the poll also found that the rate of diabetes in the United States has reached a record high.

The use of GLP-1 weight loss drugs has risen sharply, contributing to the decline in obesity rates.

Author's summary: Obesity rates in the US have declined due to increased use of weight loss drugs.

more

Healthline Healthline — 2025-10-30